UNSPSC 51172602: Fructose/glucose/phosphoric acid

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA605. This VA Drug Class (GA605) classifies this compound as belonging to the group ANTIEMETICS.

UNSPSC 51172602 Fructose/glucose/phosphoric acid is a Commodity code that appears to capture pharmaceutical and drug-testing product distribution rather than commodity chemicals aligned with its nominal name. The recent state and local opportunities solicited under this code span drug-testing services, direct-to-manufacturer prescription programs, and generic pharmaceutical supply agreements. Issuing bodies include county corrections and community supervision departments (Collin County), state health and human services agencies (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving state and local government facilities including Oregon). The work itself centers on specimen collection and laboratory drug testing, pharmacy benefit program administration and direct contracting models, and wholesale pharmaceutical distribution through certified manufacturers and authorized distributor networks.

Recent activity shows geographic spread across Texas and Minnesota with multistate participation. Collin County Community Supervision and Corrections Department issued RFP 2026-327 for offender specimen collection and drug testing services, due July 23, 2026, with an estimated annual contract value of $600,000 covering approximately 25,031 tests annually across two collection sites in Plano and McKinney; the contract runs two years from September 1, 2026, with optional one-year renewals to five years total, and the county will award to responsible contractors whose proposals represent the best evaluated offer on price and qualifications. The Texas Health and Human Services Commission posted RFI HHS0017013 in March 2026 to gather vendor capabilities regarding direct-to-manufacturer prescription programs as preliminary market intelligence before issuing a formal RFP. The Minnesota Department of Administration's Office of State Procurement, administering MMCAP, issued RFP S1070000015802 on January 20, 2026 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed through AmerisourceBergen, Cardinal Health, and Morris & Dickson, with awarded vendors effective July 1, 2026, and contract performance weighted 75 percent on price competitiveness.